• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[交界区风湿病/血液学中的克隆性疾病]

[Clonal diseases in the border zone rheumatology/hematology].

作者信息

Munder Markus

机构信息

Abteilung für Innere Medizin/Hämatologie und Internistische Onkologie, Diakonissen-Stiftungs-Krankenhaus Speyer, Paul-Egell-Str. 33, 67346, Speyer, Deutschland.

出版信息

Z Rheumatol. 2025 Jul 9. doi: 10.1007/s00393-025-01678-0.

DOI:10.1007/s00393-025-01678-0
PMID:40643638
Abstract

Chronic inflammation and disorders of immunoregulation are basic traits of inflammatory rheumatic diseases and also cofactors in the development and sequelae of plasma cell dyscrasias with associated gammopathy. Therefore, in cases of unclear rheumatological symptoms the possibility of an underlying monoclonal gammopathy of undetermined significance (MGUS) should always be considered. The thorough examination of patients with a monoclonal gammopathy is important to be able to differentiate between MGUS, monoclonal gammopathy of clinical significance (MGCS) and multiple myeloma.

摘要

慢性炎症和免疫调节紊乱是炎性风湿性疾病的基本特征,也是伴有相关丙种球蛋白病的浆细胞发育异常及其后遗症发展过程中的辅助因素。因此,对于风湿症状不明的病例,应始终考虑存在意义未明的单克隆丙种球蛋白病(MGUS)的可能性。对单克隆丙种球蛋白病患者进行全面检查,对于区分MGUS、具有临床意义的单克隆丙种球蛋白病(MGCS)和多发性骨髓瘤至关重要。

相似文献

1
[Clonal diseases in the border zone rheumatology/hematology].[交界区风湿病/血液学中的克隆性疾病]
Z Rheumatol. 2025 Jul 9. doi: 10.1007/s00393-025-01678-0.
2
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.采用质谱法对高危美国人群进行筛查后的单克隆丙种球蛋白病患病率及临床结局:一项多中心队列研究。
Lancet Haematol. 2022 May;9(5):e340-e349. doi: 10.1016/S2352-3026(22)00069-2. Epub 2022 Mar 25.
3
¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.¹⁸F-FDG PET/CT:多发性骨髓瘤及相关疾病的诊断和预后特征综述
Clin Exp Med. 2015 Feb;15(1):1-18. doi: 10.1007/s10238-014-0308-3. Epub 2014 Sep 14.
4
Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a systematic review.先前的自身免疫性疾病与意义未明的单克隆丙种球蛋白血症和多发性骨髓瘤风险:系统评价。
Cancer Epidemiol Biomarkers Prev. 2014 Feb;23(2):332-42. doi: 10.1158/1055-9965.EPI-13-0695. Epub 2014 Jan 22.
5
Mass spectrometry-based lipidomics identifies select triacylglycerol species as differentially abundant in the bone marrow microenvironment of patients with multiple myeloma compared to monoclonal gammopathy of unknown significance.基于质谱的脂质组学研究表明,与意义未明的单克隆丙种球蛋白病相比,多发性骨髓瘤患者骨髓微环境中某些三酰甘油种类的丰度存在差异。
Metabolomics. 2025 Jun 1;21(3):73. doi: 10.1007/s11306-025-02271-x.
6
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.意义未明的单克隆丙种球蛋白病和冒烟型多发性骨髓瘤
Hematol Oncol Clin North Am. 2014 Oct;28(5):775-90. doi: 10.1016/j.hoc.2014.06.005. Epub 2014 Jul 22.
7
Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma.多克隆浆细胞(PolyPC)特征作为预测意义未明的单克隆丙种球蛋白病(MGUS)进展为多发性骨髓瘤的关键指标。
Cancer Biomark. 2025 Jun;42(6):18758592251344936. doi: 10.1177/18758592251344936. Epub 2025 Jun 9.
8
Associations Between Patient Characteristics and Progression to Multiple Myeloma Among Patients With Monoclonal Gammopathy of Undetermined Significance: A Systematic Review.意义未明的单克隆丙种球蛋白病患者的特征与进展为多发性骨髓瘤之间的关联:一项系统评价
Clin Lymphoma Myeloma Leuk. 2025 Apr;25(4):e222-e231. doi: 10.1016/j.clml.2024.12.006. Epub 2024 Dec 6.
9
Differences in the proteome within extracellular vesicles between premalignant and malignant plasma cell disorders.癌前和恶性浆细胞疾病细胞外囊泡中蛋白质组的差异。
Eur J Haematol. 2024 Sep;113(3):351-356. doi: 10.1111/ejh.14246. Epub 2024 May 28.
10
Precursor plasma cell disorders: Classification, risk stratification, and emerging role of early interception.前驱浆细胞疾病:分类、风险分层及早期干预的新作用
Best Pract Res Clin Haematol. 2025 Sep;38(3):101641. doi: 10.1016/j.beha.2025.101641. Epub 2025 Jul 9.

本文引用的文献

1
Effective treatment of refractory monoclonal gammopathy-associated pure red cell aplasia with isatuximab, pomalidomide and dexamethasone.使用isatuximab、泊马度胺和地塞米松有效治疗难治性单克隆丙种球蛋白病相关纯红细胞再生障碍性贫血。
EJHaem. 2024 Jun 17;5(4):838-841. doi: 10.1002/jha2.964. eCollection 2024 Aug.
2
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance : An Analysis From a Population-Based Screening Study.自身免疫性疾病与意义未明的单克隆丙种球蛋白血症的关联:一项基于人群筛查研究的分析。
Ann Intern Med. 2024 Jun;177(6):711-718. doi: 10.7326/M23-2867. Epub 2024 May 21.
3
Monoclonal gammopathy of clinical significance: what the rheumatologist needs to know.
具有临床意义的单克隆丙种球蛋白病:风湿病学家需要了解的内容。
Lancet Rheumatol. 2022 May;4(5):e362-e373. doi: 10.1016/S2665-9913(21)00348-9. Epub 2022 Feb 15.
4
Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma.风湿性疾病会影响 MGUS 向明显多发性骨髓瘤进展的风险。
Blood Adv. 2021 Mar 23;5(6):1746-1754. doi: 10.1182/bloodadvances.2020003193.
5
Systemic immunoglobulin light chain amyloidosis.系统性免疫球蛋白轻链淀粉样变性。
Nat Rev Dis Primers. 2018 Oct 25;4(1):38. doi: 10.1038/s41572-018-0034-3.
6
Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a systematic review.先前的自身免疫性疾病与意义未明的单克隆丙种球蛋白血症和多发性骨髓瘤风险:系统评价。
Cancer Epidemiol Biomarkers Prev. 2014 Feb;23(2):332-42. doi: 10.1158/1055-9965.EPI-13-0695. Epub 2014 Jan 22.
7
Monoclonal gammopathy related to Sjögren syndrome: a key marker of disease prognosis and outcomes.与干燥综合征相关的单克隆丙种球蛋白血症:疾病预后和结局的关键标志物。
J Autoimmun. 2012 Aug;39(1-2):43-8. doi: 10.1016/j.jaut.2012.01.010. Epub 2012 Jan 31.
8
Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients.意义未明的单克隆丙种球蛋白病与疾病的关联:一项基于17398例患者的人群研究。
Mayo Clin Proc. 2009 Aug;84(8):685-93. doi: 10.4065/84.8.685.